Opinion: Medical schools diversified. So where are all the diverse doctors?

For more than two decades, medical schools have worked hard to diversify, expanding pipeline programs, scholarships, and recruitment strategies to increase representation among students from historically excluded groups. These efforts have produced measurable gains in medical school enrollment, with the proportion of Black and Latino students increasing over the past decade.

And yet, diversity in the physician workforce has remained relatively unchanged. Black and Latino physicians continue to comprise a disproportionately small share of practicing physicians. 

Read the rest…

STAT+: Executives reveal tech initiatives at Summa Health, eight months after General Catalyst acquisition

COLUMBUS, Ohio — People across northeast Ohio are now receiving AI phone calls to help them prep for surgery and navigate care after they leave the hospital. It’s all part of the “transformation” plan that venture capital firm General Catalyst is implementing at Summa Health, the Akron-based safety-net hospital it bought in October.

In some of the first media interviews since its parent company bought the health system, Health Assurance Transformation Company executives shed light on how the holding company is approaching its “transformation” of the hospital system and planning to share its innovations with more than two dozen of HATCo’s partner health systems.

The firm chose Summa to serve as a proving ground of sorts for health technology tools developed by General Catalyst’s portfolio companies. The purchase, a rare instance of a VC firm buying a hospital, was a response to the frustration that health systems are extremely slow in adopting new technology.

Continue to STAT+ to read the full story…

STAT+: Medicare still won’t say how much covering obesity drugs will cost

Medicare is advertising that adults 65 and older can get Wegovy and Zepbound, specifically for weight loss, starting in July for $50 a month. But the agency still is not sharing how much this will cost taxpayers, who will foot most of the bill.

There is a lot at stake for the public and Medicare beneficiaries. The temporary coverage of obesity medications, which sidesteps federal law, will unleash millions of new patients and billions of dollars in revenue for the drugs’ manufacturers, Eli Lilly and Novo Nordisk.

Medicare’s “GLP-1 Bridge” program starts July 1 and runs through Dec. 31, 2027. The Trump administration initially planned on testing coverage of the obesity drugs through Medicare Advantage and prescription drug plans, but the health insurers that run those plans balked at the high potential costs. Instead, the drugs will be covered solely by taxpayers and the beneficiaries who fill prescriptions. 

Continue to STAT+ to read the full story…

STAT+: No Surprises Act arbitration rule could worsen flood of provider disputes

Health insurers, providers, and consumer advocates praised the Trump administration’s long-awaited fixes to the No Surprises Act’s arbitration process, but some warned they won’t address its most pernicious problem: the provider gaming that’s costing millions. 

The final rule issued Thursday makes changes designed to improve communication between insurers and providers and give Medicare more visibility into their negotiations. Other tweaks are aimed at attacking the problems of ineligible disputes and of arbitration being used as a catch-all instead of a last resort. 

“It does make meaningful progress to reduce burdens and streamline, but we need additional action to address some of the underlying incentives that are driving overuse of the process,” said Jennifer Jones, the Blue Cross Blue Shield Association’s senior director of legislative and regulatory policy. “We need more to address the egregious award amounts.” 

Continue to STAT+ to read the full story…

Group-based ACT for Psychological Distress of Young People

Conditions: Depression – Major Depressive Disorder; Depression Anxiety Disorder; Anxiety; Anxiety Depression

Interventions: Other: Group-based Acceptance and Commitment Therapy; Other: TAU

Sponsors: Sorlandet Hospital HF; University of Oslo; Helse Sor-Ost; Karolinska Institutet; Australian Catholic University

Recruiting

Student Precarity and Psychiatry

Conditions: Depressive Disorder, Major; Generalized Anxiety Disorder; Suicidal Ideation; Loneliness

Interventions: Other: Questionnaires

Sponsors: Assistance Publique – Hôpitaux de Paris; Institut de Psychiatrie et Neurosciences de Paris (INSERM)

Not yet recruiting